Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.

Sumiyoshi T, Iijima K, Fujiki S, Hirabayashi K, Matsumoto H, Kuroda S, Hayashi H, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Kubota Y, Tomita H, Anzai T, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Fukaya H, Maemura K, Umemoto T, Katou R, Saigawa T, Naito S, Ando K, Yano M, Nitta J, Miura T, Yamashita Y, Kario K, Igarashi M, Yoshida H, Tanaka T, Node K, Minamino T.

Open source

DOI
10.1161/circulationaha.125.077634
Published
2026-04-27
Container
Circulation
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1161/circulationaha.125.077634,
  title = {Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.},
  author = {Sumiyoshi T and  Iijima K and  Fujiki S and  Hirabayashi K and  Matsumoto H and  Kuroda S and  Hayashi H and  Nakagawa Y and  Takahashi K and  Okabe M and  Kusano K and  Owada S and  Kondo Y and  Tsujita K and  Kubota Y and  Tomita H and  Anzai T and  Shoda M and  Watanabe M and  Tokano T and  Murohara T and  Kaneshiro T and  Kato T and  Fukaya H and  Maemura K and  Umemoto T and  Katou R and  Saigawa T and  Naito S and  Ando K and  Yano M and  Nitta J and  Miura T and  Yamashita Y and  Kario K and  Igarashi M and  Yoshida H and  Tanaka T and  Node K and  Minamino T.},
  year = {2026},
  journal = {Circulation},
  doi = {10.1161/circulationaha.125.077634},
  url = {https://doi.org/10.1161/circulationaha.125.077634}
}

RIS

TY  - JOUR
TI  - Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.
AU  - Sumiyoshi T
AU  -  Iijima K
AU  -  Fujiki S
AU  -  Hirabayashi K
AU  -  Matsumoto H
AU  -  Kuroda S
AU  -  Hayashi H
AU  -  Nakagawa Y
AU  -  Takahashi K
AU  -  Okabe M
AU  -  Kusano K
AU  -  Owada S
AU  -  Kondo Y
AU  -  Tsujita K
AU  -  Kubota Y
AU  -  Tomita H
AU  -  Anzai T
AU  -  Shoda M
AU  -  Watanabe M
AU  -  Tokano T
AU  -  Murohara T
AU  -  Kaneshiro T
AU  -  Kato T
AU  -  Fukaya H
AU  -  Maemura K
AU  -  Umemoto T
AU  -  Katou R
AU  -  Saigawa T
AU  -  Naito S
AU  -  Ando K
AU  -  Yano M
AU  -  Nitta J
AU  -  Miura T
AU  -  Yamashita Y
AU  -  Kario K
AU  -  Igarashi M
AU  -  Yoshida H
AU  -  Tanaka T
AU  -  Node K
AU  -  Minamino T.
PY  - 2026
JO  - Circulation
DO  - 10.1161/circulationaha.125.077634
UR  - https://doi.org/10.1161/circulationaha.125.077634
ER  - 

APA

T, S., K, I., S, F., K, H., H, M., S, K., H, H., Y, N., K, T., M, O., K, K., S, O., Y, K., K, T., Y, K., H, T., T, A., M, S., M, W., T, T., T, M., T, K., T, K., H, F., K, M., T, U., R, K., T, S., S, N., K, A., M, Y., J, N., T, M., Y, Y., K, K., M, I., H, Y., T, T., K, N., & T., M. (2026). Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.. Circulation. https://doi.org/10.1161/circulationaha.125.077634

Source records